{"id":11251,"date":"2024-03-07T09:24:19","date_gmt":"2024-03-07T08:24:19","guid":{"rendered":"https:\/\/kloepfel.sempre-diritto.de\/2024\/03\/07\/bayer-will-performance-steigern\/"},"modified":"2025-08-27T11:24:19","modified_gmt":"2025-08-27T09:24:19","slug":"bayer-souhaite-ameliorer-ses-performances","status":"publish","type":"post","link":"https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/","title":{"rendered":"Bayer veut am\u00e9liorer ses performances"},"content":{"rendered":"<h2>R\u00e9duire les dettes, r\u00e9orienter le mod\u00e8le organisationnel, r\u00e9duire les risques juridiques<\/h2>\n<p>Dans le cas de l'actuel grand public <a href=\"https:\/\/kloepfel-consulting.com\/fr\/actualites-de-la-chaine-dapprovisionnement\/unternehmen\/bayer-neue-unternehmensorganisation-7804368\/\" rel=\"noopener\" target=\"_blank\">Groupe Bayer<\/a> le pr\u00e9sident du conseil d'administration Bill Anderson s'est montr\u00e9 tourn\u00e9 vers l'avenir lors de la conf\u00e9rence de presse de mardi \u00e0 Londres.<\/p>\n<p>Le groupe pharmaceutique et agrochimique de Leverkusen a indiqu\u00e9 que ses mesures de r\u00e9duction des co\u00fbts avaient \u00e9t\u00e9 ajust\u00e9es. <strong>Objectifs<\/strong> pour l'exercice 2023. Le pr\u00e9sident du conseil d'administration a d\u00e9clar\u00e9 : \u201eNous sommes une entreprise des sciences de la vie \u00e0 fort impact, port\u00e9e par une mission formidable, et nous avons trois divisions solides\u201c. Il a toutefois aussi montr\u00e9 qu'il \u00e9tait urgent d'agir \u00e0 plusieurs endroits.<\/p>\n<h3>Mod\u00e8le d'organisation - pas de scission<\/h3>\n<p>Selon son communiqu\u00e9 de presse, Bayer a l'intention de construire un solide pipeline pharmaceutique au cours des 24 \u00e0 36 prochains mois, de r\u00e9duire les risques juridiques et de diminuer l'endettement. En outre, le groupe a l'intention de poursuivre la mise en place du nouveau mod\u00e8le d'organisation appel\u00e9 Shared Ownership (DSO). Pour ce <em>Mod\u00e8le d'organisation<\/em>, Bayer avait d\u00e9j\u00e0 pris la d\u00e9cision il y a plusieurs semaines de mettre en place un syst\u00e8me de gestion de la qualit\u00e9 qui r\u00e9duirait la hi\u00e9rarchie, \u00e9liminerait la bureaucratie et acc\u00e9l\u00e9rerait les processus de d\u00e9cision.<\/p>\n<p>Les plans pr\u00e9sent\u00e9s mardi doivent permettre d'am\u00e9liorer la performance globale du groupe. Selon ses explications, Bayer a l'intention de se concentrer intensivement sur les clients et les produits et d'\u00eatre plus mince et plus efficace que ses concurrents dans chaque activit\u00e9 de l'entreprise.<\/p>\n<p>Afin de r\u00e9duire les risques juridiques et les incertitudes qui y sont li\u00e9es, l'entreprise affirme qu'elle adaptera sa strat\u00e9gie et adoptera de nouvelles approches \u00e0 l'int\u00e9rieur et \u00e0 l'ext\u00e9rieur des tribunaux.<\/p>\n<p>Bill Anderson a rejet\u00e9 pour l'instant l'id\u00e9e d'une scission du groupe Bayer, comme cela est souvent demand\u00e9 publiquement actuellement. Toutefois, Anderson a d\u00e9clar\u00e9 \u00e0 ce sujet : \u201eBien s\u00fbr, nous resterons ouverts \u00e0 tout\u201c.\u201c<\/p>\n<h3>Chiffre d'affaires plus faible<\/h3>\n<p>2023, le chiffre d'affaires consolid\u00e9 corrig\u00e9 des effets de change et de portefeuille (wpb.) a diminu\u00e9 de 1,2 % par rapport \u00e0 l'ann\u00e9e pr\u00e9c\u00e9dente, pour atteindre environ 47,63 milliards d'euros. L'EBITDA avant effets sp\u00e9ciaux a diminu\u00e9 de 13,4 % pour atteindre environ 11,70 milliards d'euros. La marge EBITDA avant effets sp\u00e9ciaux a atteint 24,6 pour cent. En 2023, elle \u00e9tait donc inf\u00e9rieure de 2 points de pourcentage \u00e0 celle de 2022.<\/p>\n<h3>Perspectives<\/h3>\n<p>Pour l'ann\u00e9e en cours, Bayer s'attend \u00e0 un chiffre d'affaires corrig\u00e9 des effets de change compris entre 47 milliards et 49 milliards d'euros. Selon Bayer, l'EBITDA avant effets exceptionnels, corrig\u00e9 des effets de change, pourrait se situer entre 10,7 et 11,3 milliards d'euros. En ce qui concerne l'endettement financier net, le groupe indique qu'il s'attend \u00e0 un montant compris entre 32,5 milliards et 33,5 milliards d'euros (apr\u00e8s correction des effets de change) \u00e0 la fin de l'ann\u00e9e 2024.<\/p>","protected":false},"excerpt":{"rendered":"<p>Schulden abbauen, Organisationsmodell neu ausrichten, rechtliche Risiken reduzieren Beim aktuell stark unter \u00f6ffentlicher Beobachtung stehenden Bayer-Konzern \u00e4u\u00dferte sich der Vorstandsvorsitzende Bill Anderson am Dienstag w\u00e4hrend der Bilanz-Pressekonferenz in London zukunftsorientiert. Der Leverkusener Pharma- und Agrarchemiekonzern berichtete, seine angepassten Ziele f\u00fcr das Gesch\u00e4ftsjahr 2023 erreicht zu haben. Der Vorstandsvorsitzende sagte: \u201eWir sind ein Life-Science-Unternehmen mit hoher [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11252,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[88],"tags":[],"referenzkategorie":[],"class_list":["post-11251","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-supply-chain-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Bayer will Performance steigern<\/title>\n<meta name=\"description\" content=\"Beim aktuell stark unter \u00f6ffentlicher Beobachtung stehenden Bayer-Konzern \u00e4u\u00dferte sich der Vorstandsvorsitzende Bill Anderson am Dienstag\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kloepfel-consulting.com\/fr\/actualites-de-la-chaine-dapprovisionnement\/bayer-will-performance-steigern-11251\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bayer will Performance steigern\" \/>\n<meta property=\"og:description\" content=\"Beim aktuell stark unter \u00f6ffentlicher Beobachtung stehenden Bayer-Konzern \u00e4u\u00dferte sich der Vorstandsvorsitzende Bill Anderson am Dienstag w\u00e4hrend der Bilanz-Pressekonferenz in London zukunftsorientiert.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kloepfel-consulting.com\/fr\/actualites-de-la-chaine-dapprovisionnement\/bayer-will-performance-steigern-11251\/\" \/>\n<meta property=\"og:site_name\" content=\"KLOEPFEL by EPSA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/KloepfelGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-07T08:24:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-27T09:24:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/07\/kloepfelgroup.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2200\" \/>\n\t<meta property=\"og:image:height\" content=\"1608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"semprediritto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Bayer: Performance-Steigerung 2023\" \/>\n<meta name=\"twitter:description\" content=\"Erfahren Sie mehr \u00fcber Bayers neue Strategien zur Performance-Steigerung und Schuldenabbau.\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"semprediritto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/supply-chain-news\\\/bayer-will-performance-steigern-11251\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/supply-chain-news\\\/bayer-will-performance-steigern-11251\\\/\"},\"author\":{\"name\":\"semprediritto\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/person\\\/2691163984d9670e417622b00a4c0f26\"},\"headline\":\"Bayer will Performance steigern\",\"datePublished\":\"2024-03-07T08:24:19+00:00\",\"dateModified\":\"2025-08-27T09:24:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/supply-chain-news\\\/bayer-will-performance-steigern-11251\\\/\"},\"wordCount\":376,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/supply-chain-news\\\/bayer-will-performance-steigern-11251\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Bayer-Aspirin-tablet-e1709729442299.jpg\",\"articleSection\":[\"Supply Chain News\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/supply-chain-news\\\/bayer-will-performance-steigern-11251\\\/#respond\"]}],\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/supply-chain-news\\\/bayer-will-performance-steigern-11251\\\/\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/supply-chain-news\\\/bayer-will-performance-steigern-11251\\\/\",\"name\":\"Bayer will Performance steigern\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/supply-chain-news\\\/bayer-will-performance-steigern-11251\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/supply-chain-news\\\/bayer-will-performance-steigern-11251\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Bayer-Aspirin-tablet-e1709729442299.jpg\",\"datePublished\":\"2024-03-07T08:24:19+00:00\",\"dateModified\":\"2025-08-27T09:24:19+00:00\",\"description\":\"Beim aktuell stark unter \u00f6ffentlicher Beobachtung stehenden Bayer-Konzern \u00e4u\u00dferte sich der Vorstandsvorsitzende Bill Anderson am Dienstag\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/supply-chain-news\\\/bayer-will-performance-steigern-11251\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/supply-chain-news\\\/bayer-will-performance-steigern-11251\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/supply-chain-news\\\/bayer-will-performance-steigern-11251\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Bayer-Aspirin-tablet-e1709729442299.jpg\",\"contentUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Bayer-Aspirin-tablet-e1709729442299.jpg\",\"width\":1941,\"height\":1346,\"caption\":\"Runde Bayer Aspirin Tablette auf blauer Fl\u00e4che.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/supply-chain-news\\\/bayer-will-performance-steigern-11251\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/kloepfel-consulting.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bayer will Performance steigern\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#website\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/\",\"name\":\"KLOEPFEL by EPSA\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#organization\"},\"alternateName\":\"KLOEPFELbyEPSA\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kloepfel-consulting.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#organization\",\"name\":\"KLOEPFEL by EPSA\",\"alternateName\":\"KLOEPFELbyEPSA\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/logo.webp\",\"contentUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/logo.webp\",\"width\":616,\"height\":284,\"caption\":\"KLOEPFEL by EPSA\"},\"image\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/KloepfelGroup\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/kloepfel-consulting-gmbh\",\"https:\\\/\\\/www.instagram.com\\\/kloepfel_by_epsa\\\/\"],\"description\":\"Einkaufsberatung f\u00fcr Einkauf, Logistik und Supply Chain\",\"email\":\"info@kloepfel-consulting.com\",\"telephone\":\"+4921194198433\",\"legalName\":\"Kloepfel Consulting GmbH\",\"foundingDate\":\"2007-02-01\",\"vatID\":\"DE254132249\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"51\",\"maxValue\":\"200\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/person\\\/2691163984d9670e417622b00a4c0f26\",\"name\":\"semprediritto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g\",\"caption\":\"semprediritto\"},\"sameAs\":[\"https:\\\/\\\/kloepfel.sempre-diritto.de\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Bayer veut am\u00e9liorer ses performances","description":"Le pr\u00e9sident du directoire de Bayer, Bill Anderson, s'est exprim\u00e9 mardi sur le groupe Bayer, actuellement tr\u00e8s surveill\u00e9 par le public.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kloepfel-consulting.com\/fr\/actualites-de-la-chaine-dapprovisionnement\/bayer-will-performance-steigern-11251\/","og_locale":"fr_FR","og_type":"article","og_title":"Bayer will Performance steigern","og_description":"Beim aktuell stark unter \u00f6ffentlicher Beobachtung stehenden Bayer-Konzern \u00e4u\u00dferte sich der Vorstandsvorsitzende Bill Anderson am Dienstag w\u00e4hrend der Bilanz-Pressekonferenz in London zukunftsorientiert.","og_url":"https:\/\/kloepfel-consulting.com\/fr\/actualites-de-la-chaine-dapprovisionnement\/bayer-will-performance-steigern-11251\/","og_site_name":"KLOEPFEL by EPSA","article_publisher":"https:\/\/www.facebook.com\/KloepfelGroup","article_published_time":"2024-03-07T08:24:19+00:00","article_modified_time":"2025-08-27T09:24:19+00:00","og_image":[{"width":2200,"height":1608,"url":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/07\/kloepfelgroup.webp","type":"image\/webp"}],"author":"semprediritto","twitter_card":"summary_large_image","twitter_title":"Bayer: Performance-Steigerung 2023","twitter_description":"Erfahren Sie mehr \u00fcber Bayers neue Strategien zur Performance-Steigerung und Schuldenabbau.","twitter_misc":{"\u00c9crit par":"semprediritto","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/#article","isPartOf":{"@id":"https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/"},"author":{"name":"semprediritto","@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/person\/2691163984d9670e417622b00a4c0f26"},"headline":"Bayer will Performance steigern","datePublished":"2024-03-07T08:24:19+00:00","dateModified":"2025-08-27T09:24:19+00:00","mainEntityOfPage":{"@id":"https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/"},"wordCount":376,"commentCount":0,"publisher":{"@id":"https:\/\/kloepfel-consulting.com\/#organization"},"image":{"@id":"https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/#primaryimage"},"thumbnailUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Bayer-Aspirin-tablet-e1709729442299.jpg","articleSection":["Supply Chain News"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/#respond"]}],"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/kloepfel-consulting.com\/fr\/#organization"}},{"@type":"WebPage","@id":"https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/","url":"https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/","name":"Bayer veut am\u00e9liorer ses performances","isPartOf":{"@id":"https:\/\/kloepfel-consulting.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/#primaryimage"},"image":{"@id":"https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/#primaryimage"},"thumbnailUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Bayer-Aspirin-tablet-e1709729442299.jpg","datePublished":"2024-03-07T08:24:19+00:00","dateModified":"2025-08-27T09:24:19+00:00","description":"Le pr\u00e9sident du directoire de Bayer, Bill Anderson, s'est exprim\u00e9 mardi sur le groupe Bayer, actuellement tr\u00e8s surveill\u00e9 par le public.","breadcrumb":{"@id":"https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/#primaryimage","url":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Bayer-Aspirin-tablet-e1709729442299.jpg","contentUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Bayer-Aspirin-tablet-e1709729442299.jpg","width":1941,"height":1346,"caption":"Runde Bayer Aspirin Tablette auf blauer Fl\u00e4che."},{"@type":"BreadcrumbList","@id":"https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/bayer-will-performance-steigern-11251\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/kloepfel-consulting.com\/"},{"@type":"ListItem","position":2,"name":"Bayer will Performance steigern"}]},{"@type":"WebSite","@id":"https:\/\/kloepfel-consulting.com\/#website","url":"https:\/\/kloepfel-consulting.com\/","name":"KLOEPFEL by EPSA","description":"","publisher":{"@id":"https:\/\/kloepfel-consulting.com\/#organization"},"alternateName":"KLOEPFELbyEPSA","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kloepfel-consulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/kloepfel-consulting.com\/#organization","name":"KLOEPFEL by EPSA","alternateName":"KLOEPFELbyEPSA","url":"https:\/\/kloepfel-consulting.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/logo\/image\/","url":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/04\/logo.webp","contentUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/04\/logo.webp","width":616,"height":284,"caption":"KLOEPFEL by EPSA"},"image":{"@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/KloepfelGroup","https:\/\/www.linkedin.com\/company\/kloepfel-consulting-gmbh","https:\/\/www.instagram.com\/kloepfel_by_epsa\/"],"description":"Conseil d'achat pour l'approvisionnement, la logistique et la cha\u00eene d'approvisionnement","email":"info@kloepfel-consulting.com","telephone":"+4921194198433","legalName":"Kloepfel Consulting GmbH","foundingDate":"2007-02-01","vatID":"DE254132249","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"51","maxValue":"200"}},{"@type":"Person","@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/person\/2691163984d9670e417622b00a4c0f26","name":"Toujours le droit","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g","caption":"semprediritto"},"sameAs":["https:\/\/kloepfel.sempre-diritto.de"]}]}},"_links":{"self":[{"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/posts\/11251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/comments?post=11251"}],"version-history":[{"count":2,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/posts\/11251\/revisions"}],"predecessor-version":[{"id":14591,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/posts\/11251\/revisions\/14591"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/media\/11252"}],"wp:attachment":[{"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/media?parent=11251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/categories?post=11251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/tags?post=11251"},{"taxonomy":"referenzkategorie","embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/referenzkategorie?post=11251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}